Debnath Tanya, Chelluri Lakshmi Kiran
Global Medical Education & Research Foundation, Hyderabad, India.
Transplant Immunology & Stem Cell Unit, Gleneagles Global Hospitals, Hyderabad, India.
Hematol Transfus Cell Ther. 2019 Jan-Mar;41(1):7-16. doi: 10.1016/j.htct.2018.05.001. Epub 2018 Jun 19.
Mesenchymal stem cells have immense potential in stem cell-based therapies, however there is a pre-requisite to develop a curative cell dose. Adipose tissue-derived mesenchymal stem cells are promising mainly due to their potential abundance, immunomodulatory effect and remarkable differentiation potential. Nevertheless, senescence may develop during their expansion due to the incidence of genetic instability. Hence, it is important to attain an ideal balance between mesenchymal stem cell growth, quality and genetic integrity before their clinical use.
Stromal vascular fraction was obtained from omentum tissue of patients undergoing liposuction procedures for morbid obesity. This study standardized a closed system protocol which can be utilized for clinical grade stem cell derivation. Stages of cell growth and characterization of human adipose tissue-derived mesenchymal stem cells were also assessed along with the chromosomal stability in these cultures.
Human adipose tissue-derived mesenchymal stem cells maintained their spindle-shaped morphology and were able to proliferate and renew, confirming their suitability for cultivation and generate clinical grade mesenchymal stem cells. Immunophenotyping indicates that the cells expressed cluster of differentiation (CD)73/CD90/CD105, mesenchymal stem-cell markers, while lacked CD34/CD45/ Human Leukocyte antigen-antigen D related (HLA-DR) expression (hematopoietic cell markers). A cell cycle study demonstrated growth kinetics under culture conditions. Human adipose tissue derived mesenchymal stem cells expressed normal cell karyotype by chromosomal G-banding indicating their genetic stability at Passage 5. Mesenchymal stem cells also demonstrated trilineage differentiation.
Availability of adipose tissue in abundance is a major advantage for clinical applications. Furthermore, detailed characterization of human adipose tissue-derived mesenchymal stem cells, their genomic stability and differentiation potential from stromal vascular fraction of human adipose tissue would help assist in tissue regeneration and repair.
间充质干细胞在基于干细胞的治疗中具有巨大潜力,然而开发有效的细胞剂量是一个先决条件。脂肪组织来源的间充质干细胞前景广阔,主要因其潜在的丰富性、免疫调节作用和显著的分化潜能。然而,由于遗传不稳定性的发生,它们在扩增过程中可能会出现衰老。因此,在临床应用前,在间充质干细胞的生长、质量和遗传完整性之间达到理想平衡非常重要。
从接受病态肥胖抽脂手术患者的网膜组织中获取基质血管成分。本研究标准化了一种可用于临床级干细胞衍生的封闭系统方案。还评估了人脂肪组织来源的间充质干细胞的细胞生长阶段和特征以及这些培养物中的染色体稳定性。
人脂肪组织来源的间充质干细胞保持其纺锤形形态,能够增殖和更新,证实它们适合培养并产生临床级间充质干细胞。免疫表型分析表明,这些细胞表达分化簇(CD)73/CD90/CD105,即间充质干细胞标志物,而缺乏CD34/CD45/人白细胞抗原-DR相关抗原(HLA-DR)表达(造血细胞标志物)。细胞周期研究证明了培养条件下的生长动力学。通过染色体G带分析,人脂肪组织来源的间充质干细胞表达正常的细胞核型,表明它们在第5代时具有遗传稳定性。间充质干细胞也表现出三系分化。
丰富的脂肪组织可获取性是临床应用的一个主要优势。此外,对人脂肪组织来源的间充质干细胞的详细表征、它们的基因组稳定性以及来自人脂肪组织基质血管成分的分化潜能将有助于组织再生和修复。